Align Technology, Inc. with ticker code (ALGN) have now 12 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 450 and 270 with the average target price sitting at $397.92. Given that the stocks previous close was at $325.32 and the analysts are correct then there would likely be a percentage uptick in value of 22.3%. The 50 day MA is $353.28 and the 200 moving average now moves to $307.77. The market cap for the company is 24.34B. The current share price for the company is: 318 USD
The potential market cap would be $29,769,038,585 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 79.9, revenue per share of 48.37 and a 6.02% return on assets.
Align Technology, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture and marketing of Invisalign clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (GPs), Vivera retainers for retention, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software. It operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services (Systems and Services). Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals. Its Systems and Services segment consists of iTero intraoral scanning systems.
